THE LANCET 2022

Changes in type 2 diabetes incidence and mortality associated with introduction of HbA1c as diagnostic option: A Danish 24-year population-based study

Jakob S. Knudsen, Signe S. Knudsen, Adam Hulman, Daniel R. Witte, Edward W. Gregg, Torsten Lauritzen, Lars Pedersen, Henrik T. Sørensen, and Reimar W. Thomsen

Previous
Previous

Acquavella et al BMJ 2022

Next
Next

Acquavella et al Clinical Epidemiology 2016